HEC585 dose A
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Sunshine Lake Pharma Co., Ltd.
Overview
HEC585 dose A is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
HEC585 dose A clinical trials
Explore related
Medical disclaimer. This page summarizes research about HEC585 dose A for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.